Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clopidogrel (Plavix) desensitization: a case series.

Miguel G Camara1, Francis Q Almeda

  • 1Allergy & Asthma Family Clinic, Hinsdale Hospital, Hinsdale, IL 60521, USA. mcamara@ameritech.net

Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|June 24, 2005
PubMed
Summary

Patients allergic to clopidogrel (Plavix) can undergo rapid desensitization. An 8-hour protocol using oral doses allows safe, continued use of this crucial cardiovascular medication.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clopidogrel (Plavix) desensitization protocol.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2006
Same author

Coronary revascularization in multivessel disease. Which is better, stents or surgery?

Postgraduate medicine·2005
Same author

Clinical and angiographic outcomes of cardiac transplant patients treated with intracoronary beta-radiation for in-stent restenosis: a case series.

Cardiovascular radiation medicine·2005
Same author

Clinical and angiographic profile of patients with markedly elevated coronary calcium scores (>or=1000) detected by electron beam computed tomography.

Cardiovascular radiation medicine·2005
Same author

The effect of percutaneous transmyocardial laser revascularization on left ventricular function in a porcine model of hibernating myocardium: a pilot study.

Cardiovascular radiation medicine·2005
Same author

Spontaneous coronary artery dissection.

Clinical cardiology·2004

Area of Science:

  • Cardiology
  • Clinical Pharmacology
  • Immunology

Background:

  • Clopidogrel (Plavix) is a vital antiplatelet medication for cardiovascular disease, especially post-stent and acute coronary syndromes.
  • Allergic rashes are a common side effect, often necessitating treatment discontinuation.
  • Type I allergic reactions may be candidates for drug desensitization protocols.

Observation:

  • A case series evaluated an 8-hour oral clopidogrel desensitization protocol.
  • The protocol involved 15 escalating doses to reach a daily maintenance dose of 75 mg.
  • This method aimed to enable continued safe use of clopidogrel in allergic patients.

Findings:

  • The described protocol rapidly desensitized patients with Type I allergy to clopidogrel.

Related Experiment Videos

  • This suggests a potential strategy for managing clopidogrel allergy.

    • Implications:

    • This desensitization protocol may allow patients with cardiovascular conditions to continue essential clopidogrel therapy despite allergy.
    • Further large-scale studies are needed to confirm the safety and efficacy of this rapid desensitization regimen.